INCYTE CORPORATION Restricted Cash and Investments
INCYTE CORPORATION (INCY) had Restricted Cash and Investments of $13.90 million as of 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndInvestments · last filed 2016-05-09
- 2016-03-31: Restricted Cash and Investments $13.90M.
- 2015-12-31: Restricted Cash and Investments $14.00M.
- 2015-09-30: Restricted Cash and Investments $14.10M.
- 2015-06-30: Restricted Cash and Investments $14.30M.
| Period end | Restricted Cash and Investments |
|---|---|
| 2016-03-31 | $13.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $14.00M 10-Q · filed 2016-05-09 |
| 2015-09-30 | $14.10M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $14.30M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $14.40M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $14.50M 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |